- Live market news
- Stocks
- GMAB
Genmab AS
GMABStockUSA
Genmab AS
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.
Key figures
- Previous close
- 37.37
- Open
- 37.23
- Day range
- 36.81 – 37.23
- 52-week range
- —
- Volume
- 888K
Latest news on GMABranked by Oyticker for market impact
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 37.23
- Prev. close
- 37.37
Risk · 1 year
Seasonality
What GMAB filed
- 10 Nov 2026
- 5 Nov 2026
- 28 Oct 2026
- 23 Oct 2026
- 13 Oct 2026
- 7 Oct 2026
- 5 Oct 2026
- 2 Oct 2026
- 29 Sept 2026
- 24 Sept 2026
- 9 Sept 2026
- 8 Sept 2026
- 8 Sept 2026
- 12 Aug 2026
- 11 Aug 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.